Compare Medpace Holdings Inc (MEDP) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Roblox Corp — how do they compare? Medpace Holdings Inc trades at $533.39 (market cap $15.08B), while Roblox Corp trades at $52.92 (market cap $38.13B). The key difference: Roblox Corp is far larger — about 2.5× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals.
| MEDP | RBLX | |
|---|---|---|
Market Cap | $15.08B | $38.13B |
Sector | Technology | Media |
52-Week High | $620.59 | $141.56 |
52-Week Low | $308.88 | $41.30 |
Enterprise Value | $14.55B | $36.71B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Roblox trades at $54.08, up 4.64% today, showing positive momentum despite a bearish technical signal. The company continues to demonstrate strong revenue growth with $4.89B in 2025, though it remains unprofitable with a -20.69% net margin. Recent product innovation includes the launch of 'Build,' an AI-powered game creation tool, while facing multiple class-action lawsuits alleging securities fraud between October 2025 and April 2026.
While analyst consensus remains positive with a $59.62 price target and 51% buy ratings, investors face significant risks from ongoing litigation and persistent profitability challenges. The stock's high P/B ratio of 85.65 suggests premium valuation despite negative returns on equity, creating a mixed investment case dependent on future margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
